Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer Journal of Clinical Oncology
Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research
The effect of post-mastectomy radiation in women with one to three positive nodes enrolled on the control arm of BCIRG-005 at ten year follow-up Radiotherapy and Oncology
The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer The Oncologist
The application of electronic medical records (EMRs) as a virtual comparator arm in a lung cancer clinical trial: A case study Journal of Clinical Oncology
The Project Data Sphere Initiative: Accelerating Cancer Research by Sharing Data The Oncologist
Sounding Board: Advantages of a Truly Open-Access Data-Sharing Model New England Journal of Medicine
Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. PLOS ONE
Overcoming barriers to develop a broad access data sharing platform Journal of Clinical Oncology
Progress towards accurate prediction of overall survival in men with metastatic castration-resistant prostate cancer Journal of Xiangya Medicine
Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis The Lancet Oncology
Prediction of Overall Survival for Patients with Metastatic Castration-Resistant Prostate Cancer: Development of a Prognostic Model Through a Crowdsourced Challenge with Open Clinical Trial Data The Lancet Oncology
“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials? Clinical Pharmacology & Therapeutics
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel European Urology

Pages